<p>Rayonier Advanced Materials (RYAM) 发布了其第三季度财报。以下是 Rayonier Advanced Materials 向投资者提供的信息摘要。</p>
<h3>认识您的 ETF AI 分析师</h3>
<ul>
<li>了解 TipRanks 的_ETF_ AI 分析师如何帮助您做出更明智的投资决策</li>
<li>探索 TipRanks 用户喜爱的 ETF，并查看 <strong><em>ETF</em> AI 分析师</strong> 对您关注的 ETF 所揭示的见解。</li>
</ul>
<p>Rayonier Advanced Materials Inc. 是一家全球领先的纤维素基技术公司，专注于纤维素特种产品、生物材料及其他工业应用，在美国、加拿大和法国开展业务。该公司报告了 2025 年第三季度的业绩，净销售额下降至 3.53 亿美元，持续经营亏损减少至 400 万美元，较去年有所改善。尽管面临挑战的环境，公司仍然保持对其核心纤维素特种产品业务的战略关注，该业务展现出韧性，接近正常水平。</p>
<p>本季度的关键财务指标包括调整后的息税折旧摊销前利润（EBITDA）为 4200 万美元，较去年下降，总债务为 7.94 亿美元。公司在大多数细分市场的净销售额均出现下降，纤维素特种产品细分市场由于客户去库存和全球关税影响，销售额下降了 12%。然而，由于平均销售价格上涨和固定成本降低，该细分市场的营业收入增长了 7%。公司还报告了纤维素商品细分市场的改善，营业亏损显著减少，得益于销售价格的提高和固定成本的降低。</p>
<p>公司继续预计 2025 年将实现强劲的收官，年度调整后 EBITDA 预计将达到 1.35 亿至 1.4 亿美元。展望未来，Rayonier Advanced Materials 计划在未来两年内通过价格调整、效率提升和成本降低将 EBITDA 翻倍以上。公司还在探索其生物材料细分市场的战略机会，旨在提高盈利能力和终端市场多样性。</p>
<p>总之，Rayonier Advanced Materials 仍然致力于其长期战略，计划到 2027 年底实现超过 3 亿美元的年化 EBITDA。公司计划专注于现金管理、流动性和有序的资本配置，以支持其增长目标并为股东创造可持续价值。</p>

RYAM

<p>Rayonier Advanced Materials (RYAM) 发布了 2025 年第三季度的财报，净销售额为 3.53 亿美元，亏损减少至 400 万美元。纤维素特种产品部门销售额下降了 12%，但营业收入提高了 7%。调整后的息税折旧摊销前利润（EBITDA）为 4200 万美元，总债务为 7.94 亿美元。公司预计年调整后的 EBITDA 将在 1.35 亿至 1.4 亿美元之间，并计划在两年内将 EBITDA 翻倍。Rayonier 专注于现金管理和生物材料的战略机会，目标是在 2027 年前实现超过 3 亿美元的年化 EBITDA</p>

<p>Rayonier Advanced Materials ( (RYAM) ) has released its Q3 earnings. Here is a breakdown of the information Rayonier Advanced Materials presented to its investors.</p>
<div class="lb-trans"><p>Rayonier Advanced Materials (RYAM) 发布了其第三季度财报。以下是 Rayonier Advanced Materials 向投资者提供的信息摘要。</p>
</div><h3>Meet Your ETF AI Analyst</h3>
<div class="lb-trans"><h3>认识您的 ETF AI 分析师</h3>
</div><ul>
<li>Discover how TipRanks' <em>ETF</em> AI Analyst can help you make smarter investment decisions</li>
<li>Explore ETFs TipRanks' users love and see what insights the <strong><em>ETF</em> AI Analyst</strong> reveals about the ones you follow.</li>
</ul>
<div class="lb-trans"><ul>
<li>了解 TipRanks 的_ETF_ AI 分析师如何帮助您做出更明智的投资决策</li>
<li>探索 TipRanks 用户喜爱的 ETF，并查看 <strong><em>ETF</em> AI 分析师</strong> 对您关注的 ETF 所揭示的见解。</li>
</ul>
</div><p>Rayonier Advanced Materials Inc. is a global leader in cellulose-based technologies, specializing in cellulose specialties, biomaterials, and other industrial applications with operations in the U.S., Canada, and France. The company reported its third-quarter 2025 results, highlighting a net sales decrease to $353 million and a reduced loss from continuing operations of $4 million compared to the previous year. Despite a challenging environment, the company maintained its strategic focus on its core Cellulose Specialties business, which showed resilience and approached normalized levels.</p>
<div class="lb-trans"><p>Rayonier Advanced Materials Inc. 是一家全球领先的纤维素基技术公司，专注于纤维素特种产品、生物材料及其他工业应用，在美国、加拿大和法国开展业务。该公司报告了 2025 年第三季度的业绩，净销售额下降至 3.53 亿美元，持续经营亏损减少至 400 万美元，较去年有所改善。尽管面临挑战的环境，公司仍然保持对其核心纤维素特种产品业务的战略关注，该业务展现出韧性，接近正常水平。</p>
</div><p>Key financial metrics for the quarter included an adjusted EBITDA of $42 million, a decrease from the previous year, and a total debt of $794 million. The company faced a decline in net sales across most segments, with the Cellulose Specialties segment experiencing a 12% decrease in sales due to customer destocking and global tariff impacts. However, the segment’s operating income increased by 7% due to higher average sales prices and lower fixed costs. The company also reported improvements in the Cellulose Commodities segment, with a significant reduction in operating loss driven by increased sales prices and lower fixed costs.</p>
<div class="lb-trans"><p>本季度的关键财务指标包括调整后的息税折旧摊销前利润（EBITDA）为 4200 万美元，较去年下降，总债务为 7.94 亿美元。公司在大多数细分市场的净销售额均出现下降，纤维素特种产品细分市场由于客户去库存和全球关税影响，销售额下降了 12%。然而，由于平均销售价格上涨和固定成本降低，该细分市场的营业收入增长了 7%。公司还报告了纤维素商品细分市场的改善，营业亏损显著减少，得益于销售价格的提高和固定成本的降低。</p>
</div><p>The company continues to expect a strong finish to 2025, with annual adjusted EBITDA projected to reach $135 million to $140 million. Looking ahead, Rayonier Advanced Materials aims to more than double its EBITDA over the next two years through price actions, efficiency gains, and cost reductions. The company is also exploring strategic opportunities in its Biomaterials segment, aiming to enhance profitability and end-market diversity.</p>
<div class="lb-trans"><p>公司继续预计 2025 年将实现强劲的收官，年度调整后 EBITDA 预计将达到 1.35 亿至 1.4 亿美元。展望未来，Rayonier Advanced Materials 计划在未来两年内通过价格调整、效率提升和成本降低将 EBITDA 翻倍以上。公司还在探索其生物材料细分市场的战略机会，旨在提高盈利能力和终端市场多样性。</p>
</div><p>In conclusion, Rayonier Advanced Materials remains committed to its long-term strategy of achieving over $300 million in run-rate EBITDA by the end of 2027. The company plans to focus on cash management, liquidity, and disciplined capital allocation to support its growth objectives and deliver sustainable value to shareholders.</p>
<div class="lb-trans"><p>总之，Rayonier Advanced Materials 仍然致力于其长期战略，计划到 2027 年底实现超过 3 亿美元的年化 EBITDA。公司计划专注于现金管理、流动性和有序的资本配置，以支持其增长目标并为股东创造可持续价值。</p>
</div>

Rayonier Advanced Materials 公布 2025 年第三季度财务业绩